Filing Details

Accession Number:
0001213900-23-049754
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-06-16 17:50:05
Reporting Period:
2023-06-14
Accepted Time:
2023-06-16 17:50:05
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1769804 Augmedix Inc. AUGX () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1462559 L. Margie Traylor C/O Augmedix, Inc.
111 Sutter Street, Suite 1300
San Francisco CA 94104
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-06-14 26,530 $4.51 47,331 No 4 P Direct
Common Stock Acquisiton 2023-06-16 52,632 $0.00 99,963 No 4 M Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 M Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Restricted Stock Units Acquisiton 2023-06-16 52,632 $0.00 52,632 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 M Direct
Footnotes
  1. This transaction was executed in multiple trades ranging from $4.47 to $4.51. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
  2. Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Issuer's common stock.
  3. On June 16, 2022 (the "Grant Date"), the reporting person was granted 52,632 RSUs which vested in full on the one-year anniversary of the Grant Date.